Literature DB >> 10558999

Potential functional significance of brain-type and muscle-type nitric oxide synthase I expressed in adventitia and media of rat aorta.

P M Schwarz1, H Kleinert, U Förstermann.   

Abstract

Skeletal muscle and myocardium express microNOS I, an elongated splice variant of neuronal-type nitric oxide (NO) synthase (NOS I), and NOS III, endothelial-type NO synthase, respectively. This study was designed to elucidate whether vascular smooth muscle also contains a constitutively expressed NO synthase isoform. In the rat, microNOS I contains an insert of 102 nucleotides after nucleotide 2865 of the cDNA, yielding a protein of 164 kd. Reverse transcription-polymerase chain reaction with primers flanking this insert and with insert-specific primers indicated that endothelium-denuded rat aorta expresses both brain-type NOS I and microNOS I. RNase protection analyses with an antisense RNA probe overlapping the microNOS I insert detected significant amounts of NOS I mRNA and lesser amounts of microNOS I mRNA in endothelium-denuded aorta. Western blots using a specific polyclonal antibody recognizing NOS I and microNOS I showed a major band of the 160-kd NOS I and a lesser band of a slightly larger protein in endothelium-denuded aorta. Immunohistochemistry demonstrated low levels of NOS I/microNOS I immunoreactivity in the medial layer of rat aorta, whereas the endothelium expressed only NOS III immunoreactivity. When the adventitia also was removed, NOS I and microNOS I mRNA decreased markedly but remained detectable in the medial layer. In functional experiments with endothelium-denuded rat aortic rings (that contained no NOS III), contractions induced by KCl were markedly increased in the presence of the NOS inhibitor N(G)-nitro-L-arginine. These data demonstrate that 2 subforms of NOS I are expressed in nonendothelial components of rat aorta: NOS I and lesser amounts of microNOS I. Under certain conditions, this NOS I/microNOS I expression could serve as a backup system to the functionally predominant NOS III.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10558999     DOI: 10.1161/01.atv.19.11.2584

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  19 in total

1.  Nitric oxide synthase in human skeletal muscles related to defined fibre types.

Authors:  Karla Punkt; Matthias Fritzsche; Christoph Stockmar; Pierre Hepp; Christoph Josten; Maren Wellner; Stefan Schering; Igor B Buchwalow
Journal:  Histochem Cell Biol       Date:  2005-11-16       Impact factor: 4.304

2.  Atheroprotective effects of neuronal nitric oxide synthase in apolipoprotein e knockout mice.

Authors:  Peter J Kuhlencordt; Stefanie Hötten; Johannes Schödel; Sebastian Rützel; Kai Hu; Julian Widder; Alexander Marx; Paul L Huang; Georg Ertl
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-04-20       Impact factor: 8.311

Review 3.  Vascular aging: chronic oxidative stress and impairment of redox signaling-consequences for vascular homeostasis and disease.

Authors:  Markus M Bachschmid; Stefan Schildknecht; Reiko Matsui; Rebecca Zee; Dagmar Haeussler; Richard A Cohen; David Pimental; Bernd van der Loo
Journal:  Ann Med       Date:  2012-03-01       Impact factor: 4.709

4.  Hypoxia induces a functionally significant and translationally efficient neuronal NO synthase mRNA variant.

Authors:  Michael E Ward; Mourad Toporsian; Jeremy A Scott; Hwee Teoh; Vasanthi Govindaraju; Adrian Quan; Avraham D Wener; Guilin Wang; Siân C Bevan; Derek C Newton; Philip A Marsden
Journal:  J Clin Invest       Date:  2005-11       Impact factor: 14.808

Review 5.  Nitric oxide signalling in cardiovascular health and disease.

Authors:  Charlotte Farah; Lauriane Y M Michel; Jean-Luc Balligand
Journal:  Nat Rev Cardiol       Date:  2018-02-01       Impact factor: 32.419

Review 6.  Communication Is Key: Mechanisms of Intercellular Signaling in Vasodilation.

Authors:  Julie K Freed; David D Gutterman
Journal:  J Cardiovasc Pharmacol       Date:  2017-05       Impact factor: 3.105

Review 7.  Therapeutic effect of enhancing endothelial nitric oxide synthase (eNOS) expression and preventing eNOS uncoupling.

Authors:  Ulrich Förstermann; Huige Li
Journal:  Br J Pharmacol       Date:  2011-09       Impact factor: 8.739

8.  Expression of neuronal nitric oxide synthase splice variants in atherosclerotic plaques of apoE knockout mice.

Authors:  Johannes Schödel; P Padmapriya; Alexander Marx; Paul L Huang; Georg Ertl; Peter J Kuhlencordt
Journal:  Atherosclerosis       Date:  2009-03-14       Impact factor: 5.162

9.  Temporal hemodynamic changes in a female mouse model of systemic lupus erythematosus.

Authors:  Elena L Dent; Erin B Taylor; Jennifer M Sasser; Michael J Ryan
Journal:  Am J Physiol Renal Physiol       Date:  2020-03-09

10.  Nitric oxide synthase isoforms play distinct roles during acute peritonitis.

Authors:  Jie Ni; Rachel M McLoughlin; Alexandre Brodovitch; Pierre Moulin; Peter Brouckaert; Barbara Casadei; Olivier Feron; Nicholas Topley; Jean-Luc Balligand; Olivier Devuyst
Journal:  Nephrol Dial Transplant       Date:  2009-08-25       Impact factor: 5.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.